We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The European Centre for Disease Prevention and Control (ECDC) has reported continuing transmission of dengue fever in the Americas.
The countries reporting most cases from 1 January 2022 to the end of July 2022 are:
Brazil: 1 827 617 cases
Peru: 56 021 cases
Colombia: 32 327 cases
Nicaragua: 22 887 cases
Ecuador: 12 279 cases
Dengue fever is an infection found in tropical and subtropical climates worldwide. It is spread by Aedes mosquito bites and can cause a severe flu-like illness.
There is no vaccine against dengue licensed in the UK. Treatment is supportive only.
All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection. Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.
Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.
For further information see TRAVAX dengue fever page.
